TARRYTOWN, N.Y.–(BUSINESS WIRE)–PsychoGenics Inc. today announced that it has entered into a drug discovery agreement with Cephalon, Inc. The agreement provides that Cephalon will supply
Originally Syndicated via RSS from Business Wire Health: Mental Health News
Leave a Reply